TIME UNTIL INSULIN INITIATION FOR CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN AND EMPAGLIFLOZIN IN DUAL AND TRIPLE THERAPY FOR TYPE 2 DIABETES MELLITUS IN THE UNITED KINGDOM
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1317
https://www.valueinhealthjournal.com/article/S1098-3015(16)01385-1/fulltext
Section Title :
Diabetes/Endocrine Disorders - Clinical Outcomes Studies
Section Order :
603
First Page :
A198
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01385-1&doi=10.1016/j.jval.2016.03.1317